51 related articles for article (PubMed ID: 19439915)
1. When is a genetic test suitable for prime time? Predicting the risk of prostate cancer as a case-example.
Li-Wan-Po A; Farndon P; Cooley C; Lithgow J
Public Health Genomics; 2010; 13(1):55-62. PubMed ID: 19439915
[TBL] [Abstract][Full Text] [Related]
2. Utility of incorporating genetic variants for the early detection of prostate cancer.
Nam RK; Zhang WW; Trachtenberg J; Seth A; Klotz LH; Stanimirovic A; Punnen S; Venkateswaran V; Toi A; Loblaw DA; Sugar L; Siminovitch KA; Narod SA
Clin Cancer Res; 2009 Mar; 15(5):1787-93. PubMed ID: 19223501
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis gene polymorphisms and risk of prostate cancer: a hospital-based study of German patients treated with brachytherapy.
Meyer A; Coinac I; Bogdanova N; Dubrowinskaja N; Turmanov N; Haubold S; Schürmann P; Imkamp F; von Klot C; Merseburger AS; Machtens S; Bremer M; Hillemanns P; Kuczyk MA; Karstens JH; Serth J; Dörk T
Urol Oncol; 2013 Jan; 31(1):74-81. PubMed ID: 21396839
[TBL] [Abstract][Full Text] [Related]
4. Genetic predisposition to early recurrence in clinically localized prostate cancer.
Borque Á; del Amo J; Esteban LM; Ars E; Hernández C; Planas J; Arruza A; Llarena R; Palou J; Herranz F; Raventós CX; Tejedor D; Artieda M; Simon L; Martínez A; Carceller E; Suárez M; Allué M; Sanz G; Morote J
BJU Int; 2013 Apr; 111(4):549-58. PubMed ID: 22759231
[TBL] [Abstract][Full Text] [Related]
5. The interaction of four genes in the inflammation pathway significantly predicts prostate cancer risk.
Xu J; Lowey J; Wiklund F; Sun J; Lindmark F; Hsu FC; Dimitrov L; Chang B; Turner AR; Liu W; Adami HO; Suh E; Moore JH; Zheng SL; Isaacs WB; Trent JM; Grönberg H
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2563-8. PubMed ID: 16284379
[TBL] [Abstract][Full Text] [Related]
6. Special report: recent developments in prostate cancer genetics and genetic testing.
Technol Eval Cent Assess Program Exec Summ; 2009 Jan; 23(7):1-3. PubMed ID: 19297804
[No Abstract] [Full Text] [Related]
7. Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer.
Chen YC; Giovannucci E; Kraft P; Lazarus R; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1982-9. PubMed ID: 17932345
[TBL] [Abstract][Full Text] [Related]
8. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer.
Chen YC; Giovannucci E; Lazarus R; Kraft P; Ketkar S; Hunter DJ
Cancer Res; 2005 Dec; 65(24):11771-8. PubMed ID: 16357190
[TBL] [Abstract][Full Text] [Related]
9. Genomic analysis in active surveillance: predicting high-risk disease using tissue biomarkers.
Donovan MJ; Cordon-Cardo C
Curr Opin Urol; 2014 May; 24(3):303-10. PubMed ID: 24625431
[TBL] [Abstract][Full Text] [Related]
10. The prostate cancer risk locus at 10q11 is associated with DNA repair capacity.
Rinckleb AE; Surowy HM; Luedeke M; Varga D; Schrader M; Hoegel J; Vogel W; Maier C
DNA Repair (Amst); 2012 Aug; 11(8):693-701. PubMed ID: 22677538
[TBL] [Abstract][Full Text] [Related]
11. Y chromosome haplotypes and prostate cancer in Sweden.
Lindström S; Adami HO; Adolfsson J; Wiklund F
Clin Cancer Res; 2008 Oct; 14(20):6712-6. PubMed ID: 18927315
[TBL] [Abstract][Full Text] [Related]
12. Risk loci, biological candidates and biomarkers.
Nat Genet; 2008 Mar; 40(3):257. PubMed ID: 18305468
[No Abstract] [Full Text] [Related]
13. [Genetic predisposition to prostate cancer].
Jeanteur P
Bull Cancer; 2008 Nov; 95(11):1063-6. PubMed ID: 19036678
[TBL] [Abstract][Full Text] [Related]
14. Sequence variants of alpha-methylacyl-CoA racemase are associated with prostate cancer risk: a replication study in an ethnically homogeneous population.
FitzGerald LM; Thomson R; Polanowski A; Patterson B; McKay JD; Stankovich J; Dickinson JL
Prostate; 2008 Sep; 68(13):1373-9. PubMed ID: 18537123
[TBL] [Abstract][Full Text] [Related]
15. [Clinical and basic aspects of familial prostate cancer].
Suzuki K; Matsui H; Ohtake N
Gan To Kagaku Ryoho; 2013 Feb; 40(2):159-63. PubMed ID: 23411953
[TBL] [Abstract][Full Text] [Related]
16. Variants of the hK2 protein gene (KLK2) are associated with serum hK2 levels and predict the presence of prostate cancer at biopsy.
Nam RK; Zhang WW; Klotz LH; Trachtenberg J; Jewett MA; Sweet J; Toi A; Teahan S; Venkateswaran V; Sugar L; Loblaw A; Siminovitch K; Narod SA
Clin Cancer Res; 2006 Nov; 12(21):6452-8. PubMed ID: 17085659
[TBL] [Abstract][Full Text] [Related]
17. [Molecular genetic tests in advanced non-small cell lung cancer: practical relevance].
Sebastian M; Niederle N; Thomas M; Reck M; Schmittel A; Fischer B; Overbeck T; Gröschel A; Deppermann M; Pirker R; Huber RM; Eberhardt W; Griesinger F
Dtsch Med Wochenschr; 2014 Oct; 139(41):2096-100. PubMed ID: 25268213
[No Abstract] [Full Text] [Related]
18. The role of single nucleotide polymorphisms in predicting prostate cancer risk and therapeutic decision making.
Van den Broeck T; Joniau S; Clinckemalie L; Helsen C; Prekovic S; Spans L; Tosco L; Van Poppel H; Claessens F
Biomed Res Int; 2014; 2014():627510. PubMed ID: 24701578
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis, staging, and risk stratification in prostate cancer: Utilizing diagnostic tools to avoid unnecessary therapies and side effects.
Rodgers L; Peer CJ; Figg WD
Cancer Biol Ther; 2017 Jul; 18(7):470-472. PubMed ID: 28475407
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer: from the pathophysiologic implications of some genetic risk factors to translation in personalized cancer treatments.
Balistreri CR; Candore G; Lio D; Carruba G
Cancer Gene Ther; 2014 Jan; 21(1):2-11. PubMed ID: 24407349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]